PCSK 9 Inhibitor Therapy Pathway

Author: Dr Hannah Delaney, STH

Date Published: April 2017

Date to Review: February 2022

Pathway for initiation and monitoring of PCSK 9 inhibitors in secondary care.

Please find below the hyperlink to the STH intranet site for Local Clinical Guidelines for GPs. In order to facilitate transmission of long URLs within pathology reports, each link also have as equivalent TinyURL

STH PCSK9 Inhibitor Therapy Feb 2017